Daniel Karel
Hematology & Oncology · Jefferson, LANPI 1962999896
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 50 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 9.9% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for hematology & oncology clinicians in LA, where the typical reported total is $4,451.
Across 50 payments — averaging $81.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$405
- AstraZeneca$385
- AbbVie$288
- Seagen Inc.$246
- Sobi, Inc$244
- Bristol Myers Squibb$213
- plus $2K from 21 others
What the payments were for
- Food & beverage$4,087100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 4 | $405 |
| AstraZeneca(2 entities) | 4 | $385 |
| AbbVie | 4 | $288 |
| Seagen Inc. | 2 | $246 |
| Sobi, Inc | 2 | $244 |
| Bristol Myers Squibb | 4 | $213 |
| Pfizer | 2 | $211 |
| Foundation Medicine, Inc. | 1 | $169 |
| Daiichi Sankyo Inc. | 3 | $159 |
| Johnson & Johnson | 3 | $157 |
| Teleflex LLC | 2 | $142 |
| Gilead | 1 | $137 |
| Apellis Pharmaceuticals, Inc. | 1 | $136 |
| Genentech USA, Inc. | 1 | $133 |
| Incyte Corporation | 1 | $127 |
| Beigene USA, Inc. | 1 | $125 |
| Beone Medicines USA, Inc. | 1 | $124 |
| Blueprint Medicines Corporation | 1 | $122 |
| E.r. Squibb & Sons, L.L.C. | 1 | $114 |
| Syndax Pharmaceuticals, Inc. | 1 | $114 |
| Rigel Pharmaceuticals, Inc. | 1 | $99 |
| Novartis | 3 | $74 |
| Merck | 2 | $43 |
| Stemline Therapeutics Inc. | 1 | $41 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $32 |
| Janssen Scientific Affairs, LLC | 1 | $28 |
| Lilly USA, LLC | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BRUKINSA$249
- DOPTELET$244
- FOUNDATIONONE$169
- FOUNDATIONONE HEME$169
- FOUNDATIONONE CDX$169
- FOUNDATIONFOCUS$169
- FOUNDATIONONE LIQUID CDX$169
- Trodelvy$137
- Empaveli$136
- TAGRISSO$128
- MONJUVI$127
- SARCLISA$124
- OXBRYTA$124
- ADCETRIS$122
- ULTOMIRIS$122
- AYVAKIT$122
- Arrow$117
- Venclexta$117
- DARZALEX$116
- TECVAYLI$116
How this compares
$4,087 in reported general payments places this provider in the 45th percentile of 183 hematology & oncology providers in Louisiana.
Other hematology & oncology in Jefferson
- Hana SafahBaton Rouge$2M
- Pedro BarataNew Orleans$928K
- Maissaa JanbainNew Orleans$862K
- Nakhle SabaBaton Rouge$842K
- Marc MatranaNew Orleans$757K
- Prakash PeddiShreveport$405K
- Sanjay JunejaBaton Rouge$346K
- Lingling duNew Orleans$173K
- Kamran ShahidLake Charles$155K
- Kevin GallagherShreveport$145K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.